Jerome E Seid, MD - Medicare Hematology/oncology in Grosse Pointe Woods, MI

Jerome E Seid, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Grosse Pointe Woods, Michigan. He went to Wayne State University School Of Medicine and graduated in 1987 and has 37 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Ascension St John Hospital and his current practice location is 19229 Mack Ave Ste 24, Grosse Pointe Woods, Michigan. You can reach out to his office (for appointments etc.) via phone at (313) 884-5522.

Jerome E Seid is licensed to practice in Michigan (license number JS056352) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1407860364.

Contact Information

Jerome E Seid, MD
19229 Mack Ave Ste 24,
Grosse Pointe Woods, MI 48236-2857
(313) 884-5522
(313) 884-5521



Physician's Profile

Full NameJerome E Seid
GenderMale
SpecialityHematology/oncology
Experience37 Years
Location19229 Mack Ave Ste 24, Grosse Pointe Woods, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jerome E Seid attended and graduated from Wayne State University School Of Medicine in 1987
  NPI Data:
  • NPI Number: 1407860364
  • Provider Enumeration Date: 07/28/2006
  • Last Update Date: 02/29/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 9931174513
  • Enrollment ID: I20090625000300

Medical Identifiers

Medical identifiers for Jerome E Seid such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1407860364NPI-NPPES
4231200MedicaidMI
4234966MedicaidMI
0828767OtherMIBCN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology JS056352 (Michigan)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ascension St John HospitalDetroit, MIHospital
Ascension Macomb Oakland Hosp-warren CampusWarren, MIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Ascension St John Hospital3173424082296

News Archive

Nautic Partners completes recapitalization of HPS in partnership with management

Nautic Partners, LLC, a private equity firm with more than $2.5 billion of capital under management, today announced that it has completed a recapitalization of Healthcare Payment Specialists, LLC ("HPS") in partnership with management. HPS is a provider of payment and reimbursement solutions to hospitals and other healthcare systems.

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.

PIPC chairman encourages racial, ethnic minority Americans to get involved in CER studies

The chairman of the Partnership to Improve Patient Care, Tony Coelho, encouraged racial and ethnic minority Americans to get more involved in comparative effectiveness research studies as a way to ensure that African Americans and other people of color have access to the latest treatment options and research available.

Somaxon awarded $245,000 grant for Silenor under QTDP program

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Ovarian grafts can produce hormones for more than 7 years

Transplanting previously frozen ovarian tissue back into female cancer survivors can lead to long-term hormonal function and preservation of fertility, according to a new study by Samuel Kim from the University of Kansas Medical Center in the US. His work-, which shows that hormonal function was restored in five women 12-20 weeks after transplantation, and in one case lasted for more than seven years, appears online in the Journal of Assisted Reproduction and Genetics-, published by Springer.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jerome E Seid allows following entities to bill medicare on his behalf.
Entity NameAscension St John Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043478910
PECOS PAC ID: 3173424082
Enrollment ID: O20040115000409

News Archive

Nautic Partners completes recapitalization of HPS in partnership with management

Nautic Partners, LLC, a private equity firm with more than $2.5 billion of capital under management, today announced that it has completed a recapitalization of Healthcare Payment Specialists, LLC ("HPS") in partnership with management. HPS is a provider of payment and reimbursement solutions to hospitals and other healthcare systems.

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.

PIPC chairman encourages racial, ethnic minority Americans to get involved in CER studies

The chairman of the Partnership to Improve Patient Care, Tony Coelho, encouraged racial and ethnic minority Americans to get more involved in comparative effectiveness research studies as a way to ensure that African Americans and other people of color have access to the latest treatment options and research available.

Somaxon awarded $245,000 grant for Silenor under QTDP program

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Ovarian grafts can produce hormones for more than 7 years

Transplanting previously frozen ovarian tissue back into female cancer survivors can lead to long-term hormonal function and preservation of fertility, according to a new study by Samuel Kim from the University of Kansas Medical Center in the US. His work-, which shows that hormonal function was restored in five women 12-20 weeks after transplantation, and in one case lasted for more than seven years, appears online in the Journal of Assisted Reproduction and Genetics-, published by Springer.

Read more Medical News

› Verified 6 days ago

Entity NameAscension Medical Group Michigan
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1114133485
PECOS PAC ID: 0648180406
Enrollment ID: O20081015000289

News Archive

Nautic Partners completes recapitalization of HPS in partnership with management

Nautic Partners, LLC, a private equity firm with more than $2.5 billion of capital under management, today announced that it has completed a recapitalization of Healthcare Payment Specialists, LLC ("HPS") in partnership with management. HPS is a provider of payment and reimbursement solutions to hospitals and other healthcare systems.

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.

PIPC chairman encourages racial, ethnic minority Americans to get involved in CER studies

The chairman of the Partnership to Improve Patient Care, Tony Coelho, encouraged racial and ethnic minority Americans to get more involved in comparative effectiveness research studies as a way to ensure that African Americans and other people of color have access to the latest treatment options and research available.

Somaxon awarded $245,000 grant for Silenor under QTDP program

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Ovarian grafts can produce hormones for more than 7 years

Transplanting previously frozen ovarian tissue back into female cancer survivors can lead to long-term hormonal function and preservation of fertility, according to a new study by Samuel Kim from the University of Kansas Medical Center in the US. His work-, which shows that hormonal function was restored in five women 12-20 weeks after transplantation, and in one case lasted for more than seven years, appears online in the Journal of Assisted Reproduction and Genetics-, published by Springer.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jerome E Seid is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jerome E Seid, MD
19229 Mack Ave Ste 24,
Grosse Pointe Woods, MI 48236-2857

Ph: (313) 884-5522
Jerome E Seid, MD
19229 Mack Ave Ste 24,
Grosse Pointe Woods, MI 48236-2857

Ph: (313) 884-5522

News Archive

Nautic Partners completes recapitalization of HPS in partnership with management

Nautic Partners, LLC, a private equity firm with more than $2.5 billion of capital under management, today announced that it has completed a recapitalization of Healthcare Payment Specialists, LLC ("HPS") in partnership with management. HPS is a provider of payment and reimbursement solutions to hospitals and other healthcare systems.

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.

PIPC chairman encourages racial, ethnic minority Americans to get involved in CER studies

The chairman of the Partnership to Improve Patient Care, Tony Coelho, encouraged racial and ethnic minority Americans to get more involved in comparative effectiveness research studies as a way to ensure that African Americans and other people of color have access to the latest treatment options and research available.

Somaxon awarded $245,000 grant for Silenor under QTDP program

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Ovarian grafts can produce hormones for more than 7 years

Transplanting previously frozen ovarian tissue back into female cancer survivors can lead to long-term hormonal function and preservation of fertility, according to a new study by Samuel Kim from the University of Kansas Medical Center in the US. His work-, which shows that hormonal function was restored in five women 12-20 weeks after transplantation, and in one case lasted for more than seven years, appears online in the Journal of Assisted Reproduction and Genetics-, published by Springer.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Grosse Pointe Woods, MI

Carrie L Dul, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 19229 Mack Ave Ste 24, Grosse Pointe Woods, MI 48236
Phone: 313-884-5522    Fax: 313-884-5521
Mamta Sharma, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 19251 Mack Ave, Grosse Pointe Woods, MI 48236
Phone: 313-343-7280    Fax: 313-343-7921
Ayad M. Al-katib, MD
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 19229 Mack Ave, Suite 34, Grosse Pointe Woods, MI 48236
Phone: 313-647-3245    Fax: 313-647-3244
Dr. Ashish Bhargava, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 19251 Mack Ave Ste 333, Grosse Pointe Woods, MI 48236
Phone: 313-343-7280    Fax: 313-343-7921
Dr. Ronald D Hertz, DO
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 19251 Mack Ave, Grosse Pointe Woods, MI 48236
Phone: 313-343-3749    Fax: 313-343-7921
Thomas Joseph Loss, MD
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 19299 Mack Ave Ste 34, Grosse Pointe Woods, MI 48236
Phone: 313-647-3245    Fax: 313-647-3244
Zyad Kafri, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 19229 Mack Ave, Suite 23, Grosse Pointe Woods, MI 48236
Phone: 313-647-3245    Fax: 313-647-3244

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.